Tower Research Capital (TRC)’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.1K | Sell |
2,931
-526
| -15% | -$736 | ﹤0.01% | 4380 |
|
|
2025
Q1 | $6.12K | Buy |
3,457
+877
| +34% | +$1.55K | ﹤0.01% | 4066 |
|
|
2024
Q4 | $5.93K | Buy |
2,580
+2,337
| +962% | +$5.38K | ﹤0.01% | 4224 |
|
|
2024
Q3 | $860 | Sell |
243
-3,621
| -94% | -$12.8K | ﹤0.01% | 5251 |
|
|
2024
Q2 | $10.7K | Buy |
3,864
+1,844
| +91% | +$5.11K | ﹤0.01% | 4127 |
|
|
2024
Q1 | $13.4K | Sell |
2,020
-206
| -9% | -$1.37K | ﹤0.01% | 3398 |
|
|
2023
Q4 | $6.79K | Sell |
2,226
-2,283
| -51% | -$6.96K | ﹤0.01% | 4697 |
|
|
2023
Q3 | $6.85K | Buy |
4,509
+767
| +20% | +$1.17K | ﹤0.01% | 4548 |
|
|
2023
Q2 | $6.7K | Buy |
3,742
+429
| +13% | +$768 | ﹤0.01% | 4648 |
|
|
2023
Q1 | $4K | Buy |
3,313
+909
| +38% | +$1.1K | ﹤0.01% | 5122 |
|
|
2022
Q4 | $5K | Buy |
+2,404
| New | +$5K | ﹤0.01% | 4931 |
|
|
2022
Q3 | – | Sell |
-1,685
| Closed | -$9K | – | 6575 |
|
|
2022
Q2 | $9K | Buy |
1,685
+1,188
| +239% | +$6.35K | ﹤0.01% | 4600 |
|
|
2022
Q1 | $5K | Buy |
497
+444
| +838% | +$4.47K | ﹤0.01% | 5127 |
|
|
2021
Q4 | $1K | Buy |
+53
| New | +$1K | ﹤0.01% | 5904 |
|
|
2021
Q3 | – | Sell |
-136
| Closed | -$3K | – | 6260 |
|
|
2021
Q2 | $3K | Buy |
+136
| New | +$3K | ﹤0.01% | 4970 |
|
|
2020
Q4 | – | Sell |
-203
| Closed | -$5K | – | 5461 |
|
|
2020
Q3 | $5K | Buy |
+203
| New | +$5K | ﹤0.01% | 4383 |
|
|
2019
Q1 | – | Sell |
-62
| Closed | -$1K | – | 4362 |
|
|
2018
Q4 | $1K | Buy |
62
+52
| +520% | +$839 | ﹤0.01% | 3686 |
|
|
2018
Q3 | $1K | Buy |
10
+7
| +233% | +$700 | ﹤0.01% | 3639 |
|
|
2018
Q2 | $0 | Sell |
3
-23
| -88% | – | ﹤0.01% | 4133 |
|
|
2018
Q1 | $4K | Sell |
26
-14
| -35% | -$2.15K | ﹤0.01% | 2814 |
|
|
2017
Q4 | $8K | Buy |
+40
| New | +$8K | ﹤0.01% | 2692 |
|